Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

MYSTERIOUS: Looking into harmony biosciences s return on capital employed | Mind Blowing Facts

According to Benzinga Pro, during Q4, Harmony Biosciences (NASDAQ:HRMY) earned $22.71 million, a 336.11% increase from the preceding quarter. Harmony Biosciences also posted a total of $91.21 million in sales, a 12.98% increase since Q3. In Q3, Harmony Biosciences brought in $80.73 million in sales but lost $9.62 million in earnings.

What Is ROCE?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.